Stopping GLP-1 drugs can quickly erase cardiovascular benefits

Following a rapid increase in popularity of GLP-1 drugs for diabetes and weight loss, such as semaglutide and tirzepatide, approximately one in eight U.S. adults now take these medications, which also provide cardiovascular ...

How do GLP-1 agonists affect gene expression?

GLP-1s are building a reputation as "wonder drugs." First characterized for their ability to improve insulin release and treat diabetes, the drugs were later found to promote weight loss and improve cardiovascular health. ...

How gut bacteria and diet can reprogram fat to burn more energy

Scientists at City of Hope and the Broad Institute and Keio University have discovered how specific gut bacteria work together with the diet to flip a metabolic switch—transforming energy-storing white fat into calorie-burning ...

page 7 from 40